Owens & Minor (OMI) Competitors $6.22 -0.18 (-2.73%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$6.31 +0.09 (+1.37%) As of 02/21/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends OMI vs. MCK, COR, CAH, HSIC, PDCO, CERT, MESO, LGND, CNTA, and CLOVShould you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Certara (CERT), Mesoblast (MESO), Ligand Pharmaceuticals (LGND), Centessa Pharmaceuticals (CNTA), and Clover Health Investments (CLOV). These companies are all part of the "medical" sector. Owens & Minor vs. McKesson Cencora Cardinal Health Henry Schein Patterson Companies Certara Mesoblast Ligand Pharmaceuticals Centessa Pharmaceuticals Clover Health Investments Owens & Minor (NYSE:OMI) and McKesson (NYSE:MCK) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability, community ranking and analyst recommendations. Which has better valuation and earnings, OMI or MCK? McKesson has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOwens & Minor$10.33B0.05-$41.30M-$0.65-9.58McKesson$308.95B0.24$3.00B$21.8427.37 Is OMI or MCK more profitable? McKesson has a net margin of 0.82% compared to Owens & Minor's net margin of -0.46%. Owens & Minor's return on equity of 14.60% beat McKesson's return on equity.Company Net Margins Return on Equity Return on Assets Owens & Minor-0.46% 14.60% 2.51% McKesson 0.82%-181.26%5.34% Do insiders & institutionals believe in OMI or MCK? 98.0% of Owens & Minor shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 3.6% of Owens & Minor shares are held by insiders. Comparatively, 0.1% of McKesson shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer OMI or MCK? Owens & Minor currently has a consensus target price of $16.79, indicating a potential upside of 169.65%. McKesson has a consensus target price of $645.79, indicating a potential upside of 8.05%. Given Owens & Minor's higher probable upside, analysts clearly believe Owens & Minor is more favorable than McKesson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Owens & Minor 2 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00McKesson 0 Sell rating(s) 2 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.94 Does the media favor OMI or MCK? In the previous week, McKesson had 37 more articles in the media than Owens & Minor. MarketBeat recorded 42 mentions for McKesson and 5 mentions for Owens & Minor. McKesson's average media sentiment score of 1.44 beat Owens & Minor's score of -0.03 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owens & Minor 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral McKesson 35 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, OMI or MCK? Owens & Minor has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500. Does the MarketBeat Community believe in OMI or MCK? McKesson received 717 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 74.33% of users gave McKesson an outperform vote while only 48.21% of users gave Owens & Minor an outperform vote. CompanyUnderperformOutperformOwens & MinorOutperform Votes25648.21% Underperform Votes27551.79% McKessonOutperform Votes97374.33% Underperform Votes33625.67% SummaryMcKesson beats Owens & Minor on 14 of the 18 factors compared between the two stocks. Get Owens & Minor News Delivered to You Automatically Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMI vs. The Competition Export to ExcelMetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE ExchangeMarket Cap$493.50M$7.86B$5.82B$20.21BDividend YieldN/A2.01%4.77%3.64%P/E RatioN/A17.4718.9230.80Price / Sales0.051.12453.2915.58Price / Cash1.2510.7643.8420.60Price / Book0.522.137.644.90Net Income-$41.30M$259.21M$3.18B$1.02B7 Day Performance-16.39%-4.43%-1.95%-1.05%1 Month Performance-57.98%-15.76%-0.23%-1.09%1 Year Performance-73.18%-17.73%16.69%13.70% Owens & Minor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMIOwens & Minor4.5264 of 5 stars$6.23-2.7%$16.79+169.7%-71.4%$493.50M$10.33B-9.5813,700Upcoming EarningsAnalyst RevisionMCKMcKesson4.7147 of 5 stars$593.82-1.4%$645.79+8.8%+17.8%$75.38B$308.95B27.1951,000Insider TradePositive NewsCORCencora4.4258 of 5 stars$243.03-0.6%$277.90+14.3%+3.4%$46.97B$638.56M34.5746,000Positive NewsCAHCardinal Health4.6999 of 5 stars$126.35-0.3%$136.87+8.3%+20.2%$30.52B$226.83B23.5748,900Analyst RevisionPositive NewsHSICHenry Schein3.8914 of 5 stars$76.00-2.1%$80.09+5.4%+2.9%$9.48B$12.34B31.2825,000Upcoming EarningsPositive NewsPDCOPatterson Companies4.3047 of 5 stars$31.030.0%$26.57-14.4%+11.6%$2.74B$6.57B18.157,600Upcoming EarningsNews CoverageCERTCertara3.9691 of 5 stars$14.19-0.4%$15.92+12.2%-21.7%$2.28B$354.34M-70.951,391Gap UpMESOMesoblast0.9379 of 5 stars$17.90-2.9%$18.00+0.6%+706.4%$2.27B$5.90M0.0080Upcoming EarningsLGNDLigand Pharmaceuticals4.1531 of 5 stars$120.00+5.3%$147.00+22.5%+65.9%$2.27B$131.31M47.8180Positive NewsCNTACentessa Pharmaceuticals3.303 of 5 stars$17.07-3.1%$25.83+51.3%+59.9%$2.25B$6.85M-11.16200Insider TradeHigh Trading VolumeCLOVClover Health Investments2.2485 of 5 stars$4.46-1.8%$5.00+12.1%+365.3%$2.23B$2.03B-22.30680Positive News Related Companies and Tools Related Companies McKesson Alternatives Cencora Alternatives Cardinal Health Alternatives Henry Schein Alternatives Patterson Companies Alternatives Certara Alternatives Mesoblast Alternatives Ligand Pharmaceuticals Alternatives Centessa Pharmaceuticals Alternatives Clover Health Investments Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:OMI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owens & Minor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owens & Minor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.